• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体多特异性和脂质反应性在广泛中和抗HIV-1包膜人单克隆抗体2F5和4E10与糖蛋白41膜近端包膜表位结合中的作用。

The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.

作者信息

Alam S Munir, McAdams Mildred, Boren David, Rak Michael, Scearce Richard M, Gao Feng, Camacho Zenaido T, Gewirth Daniel, Kelsoe Garnett, Chen Pojen, Haynes Barton F

机构信息

Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, RP1 Circuit Drive, Durham, NC 27710, USA.

出版信息

J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424.

DOI:10.4049/jimmunol.178.7.4424
PMID:17372000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2262928/
Abstract

Two neutralizing human mAbs, 2F5 and 4E10, that react with the HIV-1 envelope gp41 membrane proximal region are also polyspecific autoantibodies that bind to anionic phospholipids. To determine the autoantibody nature of these Abs, we have compared their reactivities with human anti-cardiolipin mAbs derived from a primary antiphospholipid syndrome patient. To define the role of lipid polyreactivity in binding of 2F5 and 4E10 mAbs to HIV-1 envelope membrane proximal epitopes, we determined the kinetics of binding of mAbs 2F5 and 4E10 to their nominal gp41 epitopes vs liposome-gp41 peptide conjugates. Both anti-HIV-1 mAbs 2F5 and 4E10 bound to cardiolipin with K(d) values similar to those of autoimmune anti-cardiolipin Abs, IS4 and IS6. Binding kinetics studies revealed that mAb 2F5 and 4E10 binding to their respective gp41 peptide-lipid conjugates could best be defined by a two-step (encounter-docking) conformational change model. In contrast, binding of 2F5 and 4E10 mAbs to linear peptide epitopes followed a simple Langmuir model. A mouse mAb, 13H11, that cross-blocks mAb 2F5 binding to the gp41 epitope did not cross-react with lipids nor did it neutralize HIV-1 viruses. Taken together, these data demonstrate the similarity of 2F5 and 4E10 mAbs to known anti-cardiolipin Abs and support the model that mAb 2F5 and 4E10 binding to HIV-1 involves both viral lipid membrane and gp41 membrane proximal epitopes.

摘要

两种与HIV-1包膜糖蛋白41(gp41)膜近端区域发生反应的人源中和单克隆抗体(mAb)2F5和4E10也是能与阴离子磷脂结合的多特异性自身抗体。为了确定这些抗体的自身抗体性质,我们将它们与源自一名原发性抗磷脂综合征患者的人抗心磷脂单克隆抗体的反应性进行了比较。为了确定脂质多反应性在2F5和4E10单克隆抗体与HIV-1包膜膜近端表位结合中的作用,我们测定了单克隆抗体2F5和4E10与其标称的gp41表位相对于脂质体-gp41肽缀合物的结合动力学。抗HIV-1单克隆抗体2F5和4E10与心磷脂的结合解离常数(K(d))值与自身免疫性抗心磷脂抗体IS4和IS6相似。结合动力学研究表明,单克隆抗体2F5和4E10与其各自的gp41肽-脂质缀合物的结合最适合用两步(相遇-对接)构象变化模型来定义。相比之下,2F5和4E10单克隆抗体与线性肽表位的结合遵循简单的朗缪尔模型。一种能交叉阻断单克隆抗体2F5与gp41表位结合的小鼠单克隆抗体13H11,既不与脂质发生交叉反应,也不能中和HIV-1病毒。综上所述,这些数据证明了2F5和4E10单克隆抗体与已知抗心磷脂抗体的相似性,并支持了单克隆抗体2F5和4E10与HIV-1的结合涉及病毒脂质膜和gp41膜近端表位的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/51a8eb5f5cb4/nihms32519f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/f3cbed188a8b/nihms32519f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/7de26923e7ec/nihms32519f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/2781b1ff2c78/nihms32519f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/a2035c242ef4/nihms32519f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/b47c356b7706/nihms32519f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/51a8eb5f5cb4/nihms32519f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/f3cbed188a8b/nihms32519f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/7de26923e7ec/nihms32519f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/2781b1ff2c78/nihms32519f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/a2035c242ef4/nihms32519f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/b47c356b7706/nihms32519f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d5d/2262928/51a8eb5f5cb4/nihms32519f6.jpg

相似文献

1
The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes.抗体多特异性和脂质反应性在广泛中和抗HIV-1包膜人单克隆抗体2F5和4E10与糖蛋白41膜近端包膜表位结合中的作用。
J Immunol. 2007 Apr 1;178(7):4424-35. doi: 10.4049/jimmunol.178.7.4424.
2
Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.人免疫缺陷病毒1型(HIV-1)gp41膜近端外部区域中和单克隆抗体2F5和4E10的稳定对接取决于其表位区域的膜浸入深度。
J Virol. 2009 Oct;83(19):10211-23. doi: 10.1128/JVI.00571-09. Epub 2009 Jul 29.
3
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.掩盖膜近端区域表位的1型人类免疫缺陷病毒糖蛋白41抗体:抗体结合动力学、诱导及急性感染中的调节潜力
J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17.
4
Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.引发广泛中和性抗HIV抗体的困难不能用心磷脂自身反应性来解释。
AIDS. 2007 Oct 18;21(16):2131-9. doi: 10.1097/QAD.0b013e3282a4a632.
5
Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10.常见的耐受机制,但与 gp41 和脂质相关的独特交叉反应性,限制了 HIV-1 广谱中和抗体 2F5 和 4E10 的产生。
J Immunol. 2013 Aug 1;191(3):1260-75. doi: 10.4049/jimmunol.1300770. Epub 2013 Jul 3.
6
Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.HIV-1抗体2F5和4E10与预先结合到宿主和病毒膜模型系统上的gp41表位的相互作用。
Chembiochem. 2009 Apr 17;10(6):1032-44. doi: 10.1002/cbic.200800609.
7
The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.与2F5相比,广泛中和抗1型人类免疫缺陷病毒的4E10单克隆抗体更适合识别和阻断膜结合表位。
J Virol. 2008 Sep;82(18):8986-96. doi: 10.1128/JVI.00846-08. Epub 2008 Jul 2.
8
Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.结构导向的 HIV-1 广谱中和抗体 2F5 的改变揭示了其中和功能的新特性。
PLoS Pathog. 2012;8(7):e1002806. doi: 10.1371/journal.ppat.1002806. Epub 2012 Jul 19.
9
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.靶向人类免疫缺陷病毒1型糖蛋白gp41膜近端外部区域的广谱中和抗体。
J Virol. 2001 Nov;75(22):10892-905. doi: 10.1128/JVI.75.22.10892-10905.2001.
10
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.两种广泛中和HIV-1抗体中的心磷脂多特异性自身反应性。
Science. 2005 Jun 24;308(5730):1906-8. doi: 10.1126/science.1111781. Epub 2005 Apr 28.

引用本文的文献

1
Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER.支持HIV-1抗体对跨膜区的中和活性的独特膜适应特性。
Mol Pharm. 2025 May 5;22(5):2494-2508. doi: 10.1021/acs.molpharmaceut.4c01341. Epub 2025 Apr 9.
2
Ab initio prediction of specific phospholipid complexes and membrane association of HIV-1 MPER antibodies by multi-scale simulations.通过多尺度模拟对HIV-1 MPER抗体的特定磷脂复合物和膜结合进行从头预测。
Elife. 2025 Apr 7;12:RP90139. doi: 10.7554/eLife.90139.
3
Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody.

本文引用的文献

1
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses.一组M型共有包膜糖蛋白可诱导产生能中和B亚型和C亚型HIV-1原代病毒亚群的抗体。
Virology. 2006 Sep 30;353(2):268-82. doi: 10.1016/j.virol.2006.04.043.
2
Distribution and three-dimensional structure of AIDS virus envelope spikes.艾滋病病毒包膜刺突的分布及三维结构
Nature. 2006 Jun 15;441(7095):847-52. doi: 10.1038/nature04817. Epub 2006 May 24.
3
Antibody polyspecificity and neutralization of HIV-1: a hypothesis.
表位结合后产生非双层脂质纳米环境可增强中和 HIV-1 MPER 抗体。
ACS Appl Mater Interfaces. 2024 Nov 6;16(44):59934-59948. doi: 10.1021/acsami.4c13353. Epub 2024 Oct 24.
4
Intra- and inter-subtype HIV diversity between 1994 and 2018 in southern Uganda: a longitudinal population-based study.1994年至2018年乌干达南部艾滋病毒亚型内和亚型间的多样性:一项基于人群的纵向研究。
Virus Evol. 2024 Aug 24;10(1):veae065. doi: 10.1093/ve/veae065. eCollection 2024.
5
HIV Vaccine Development at a Crossroads: New B and T Cell Approaches.艾滋病疫苗研发处于十字路口:B细胞和T细胞新方法
Vaccines (Basel). 2024 Sep 12;12(9):1043. doi: 10.3390/vaccines12091043.
6
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.人体中疫苗诱导的异源 HIV-1 中和抗体 B 细胞谱系。
Cell. 2024 Jun 6;187(12):2919-2934.e20. doi: 10.1016/j.cell.2024.04.033. Epub 2024 May 17.
7
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives.广谱中和抗体用于 HIV 预防:全面综述及未来展望。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0015222. doi: 10.1128/cmr.00152-22. Epub 2024 Apr 30.
8
B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice.老年小鼠中源自B-1的抗Thy-1 B细胞会发展为淋巴瘤/白血病,其CD11b和Hamp2表达较高,这与TCL1转基因小鼠不同。
Immun Ageing. 2024 Apr 3;21(1):22. doi: 10.1186/s12979-024-00415-6.
9
Increasing intra- and inter-subtype HIV diversity despite declining HIV incidence in Uganda.尽管乌干达的艾滋病病毒发病率在下降,但艾滋病病毒亚型内和亚型间的多样性却在增加。
medRxiv. 2024 Mar 15:2024.03.14.24303990. doi: 10.1101/2024.03.14.24303990.
10
Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.在产生病毒的细胞中表达针对 Env 的中和活性弱或广谱中和抗体抑制人类免疫缺陷病毒(HIV-1)感染。
J Virol. 2024 Feb 20;98(2):e0159423. doi: 10.1128/jvi.01594-23. Epub 2024 Jan 30.
抗体多特异性与HIV-1中和作用:一种假说。
Hum Antibodies. 2005;14(3-4):59-67.
4
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).针对人类免疫缺陷病毒1型包膜糖蛋白gp120(单克隆抗体2G12)和gp41(单克隆抗体4E10和2F5)的人源单克隆抗体的长期多剂量药代动力学
Antimicrob Agents Chemother. 2006 May;50(5):1773-9. doi: 10.1128/AAC.50.5.1773-1779.2006.
5
Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.人类免疫缺陷病毒1型中和性抗-gp41 2F5抗体对特定磷脂的识别
FEBS Lett. 2006 Apr 17;580(9):2395-99. doi: 10.1016/j.febslet.2006.03.067.
6
Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.1型人类免疫缺陷病毒广泛中和抗体4E10表位的结构-功能分析
J Virol. 2006 Feb;80(4):1680-7. doi: 10.1128/JVI.80.4.1680-1687.2006.
7
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.通过人源中和抗体的被动转移在抗逆转录病毒治疗停止后延迟HIV-1反弹。
Nat Med. 2005 Jun;11(6):615-22. doi: 10.1038/nm1244. Epub 2005 May 8.
8
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.两种广泛中和HIV-1抗体中的心磷脂多特异性自身反应性。
Science. 2005 Jun 24;308(5730):1906-8. doi: 10.1126/science.1111781. Epub 2005 Apr 28.
9
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.广泛中和性抗HIV抗体4E10识别gp41中高度保守的融合相关基序的螺旋构象。
Immunity. 2005 Feb;22(2):163-73. doi: 10.1016/j.immuni.2004.12.011.
10
Identification and characterization of circulating human transitional B cells.循环人过渡性B细胞的鉴定与特征分析。
Blood. 2005 Jun 1;105(11):4390-8. doi: 10.1182/blood-2004-11-4284. Epub 2005 Feb 8.